Latest Articles
Managing Progression After Immunotherapy in Endometrial Cancer - OncLive
Managing Progression After Immunotherapy in Endometrial Cancer OncLive
Published: May 5, 2026, 12:07 p.m.
Navigating Institutional Barriers: Inventory Management and EHR Pathways in Endometrial Cancer - Pharmacy Times
Navigating Institutional Barriers: Inventory Management and EHR Pathways in Endometrial Cancer Pharmacy Times
Published: May 4, 2026, 12:43 p.m.
Therapeutic Sequencing and NCCN Guidelines in Endometrial Cancer - Pharmacy Times
Therapeutic Sequencing and NCCN Guidelines in Endometrial Cancer Pharmacy Times
Published: May 4, 2026, 12:09 p.m.
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Endometrial Cancer Treatment Market - openPR.com
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Endometrial Cancer Treatment Market openPR.com
Published: May 1, 2026, 1:51 p.m.
Kristina Lindemann: New Insights Into ctDNA Monitoring in Endometrial Cancer - Oncodaily
Kristina Lindemann: New Insights Into ctDNA Monitoring in Endometrial Cancer Oncodaily
Published: May 1, 2026, 1:44 p.m.
New Theranostic Targets Identified for Diagnosis and Treatment of Endometrial Cancer [IMAGE] - EurekAlert!
New Theranostic Targets Identified for Diagnosis and Treatment of Endometrial Cancer [IMAGE] EurekAlert!
Published: April 30, 2026, 9:35 p.m.
Research progress and future directions in circadian rhythms for uterine‑related diseases (Review).
Circadian rhythms are ~24 h endogenous rhythms driven by both central and peripheral clocks, with their core mechanism being a transcription‑translation feedback loop mediated by master clock genes. The present …
Published: April 30, 2026, midnight
The Endometrial Cancer Treatment Landscape - OncLive
The Endometrial Cancer Treatment Landscape OncLive
Published: April 29, 2026, 12:15 p.m.
Hebrew University Researchers Identify RNA Dicing as Key Driver of JAK1 Oncogenic Activity in Endometrial Cancer - MedicalResearch.com
Hebrew University Researchers Identify RNA Dicing as Key Driver of JAK1 Oncogenic Activity in Endometrial Cancer MedicalResearch.com
Published: April 29, 2026, 10:59 a.m.
ADCs Reshaping Endometrial Cancer Care - OncLive
ADCs Reshaping Endometrial Cancer Care OncLive
Published: April 28, 2026, 12:32 p.m.
Link copied to clipboard!